Viridian Therapeutics, Inc./DE (VRDN) Gross margin
Viridian Therapeutics, Inc./DE (VRDN) gross margin by fiscal year — reported gross profit divided by reported revenue.
26.7%FY2016
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | 26.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice